Case Reports
doi: 10.1016/j.genhosppsych.2012.11.004.
Epub 2013 Jan 9.
Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report
Affiliations
- PMID: 23312145
- DOI: 10.1016/j.genhosppsych.2012.11.004
Item in Clipboard
Case Reports
Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report
Gen Hosp Psychiatry.
2013 May-Jun.
Abstract
Neuroleptic malignant syndrome (NMS) is a rarely observed life-threatening medical condition due mostly to antipsychotic use. Additionally, a few case reports have suggested an association between NMS and the use of selective serotonin reuptake inhibitors (SSRIs) alone or in combination with antipsychotics. This case report presents a female patient developing NMS following the use of a combination of sertraline and paroxetine.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Neuroleptic malignant syndrome (NMS) associated with amisulpride and sertraline use: A case report and discussion.Asian J Psychiatr. 2019 Mar;41:82-83. doi: 10.1016/j.ajp.2017.10.021. Epub 2017 Nov 7. Asian J Psychiatr. 2019. PMID: 29174670 No abstract available.
-
Neuroleptic malignant syndrome after addition of paroxetine to olanzapine.J Clin Psychopharmacol. 2003 Dec;23(6):671-2. doi: 10.1097/01.jcp.0000096245.29231.a8. J Clin Psychopharmacol. 2003. PMID: 14624202 No abstract available.
-
Forme fruste of neuroleptic malignant syndrome associated with the use of sertraline.Parkinsonism Relat Disord. 2011 Mar;17(3):217-8. doi: 10.1016/j.parkreldis.2010.11.007. Epub 2010 Dec 13. Parkinsonism Relat Disord. 2011. PMID: 21147016 No abstract available.
-
Association between selective serotonin-reuptake inhibitors, second-generation antipsychotics, and neuroleptic malignant syndrome.Ann Pharmacother. 2008 Sep;42(9):1290-7. doi: 10.1345/aph.1L066. Epub 2008 Jul 15. Ann Pharmacother. 2008. PMID: 18628446 Review.
-
Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.Int Clin Psychopharmacol. 1994 Jun;9 Suppl 3:13-9. doi: 10.1142/9789814440912_0082. Int Clin Psychopharmacol. 1994. PMID: 7963446 Review.
Cited by
-
[Neuroleptic malignant syndrome].Nervenarzt. 2018 Mar;89(3):300-310. doi: 10.1007/s00115-017-0463-3. Nervenarzt. 2018. PMID: 29209753 Review. German.
-
Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.Drugs R D. 2015 Mar;15(1):45-62. doi: 10.1007/s40268-014-0078-0. Drugs R D. 2015. PMID: 25578944 Free PMC article.
-
Two cases of neuroleptic malignant syndrome in elderly patients taking atypical antipsychotics.Shanghai Arch Psychiatry. 2013 Jun;25(3):178-82. doi: 10.3969/j.issn.1002-0829.2013.03.009. Shanghai Arch Psychiatry. 2013. PMID: 24991155 Free PMC article.
-
Forced Diuresis and Expedient Blood Pressure Control in the Management of Quetiapine Induced Neuroleptic Malignant Syndrome: A Case Report.Open Access Maced J Med Sci. 2018 Jun 14;6(7):1267-1270. doi: 10.3889/oamjms.2018.160. eCollection 2018 Jul 20. Open Access Maced J Med Sci. 2018. PMID: 30087734 Free PMC article.
-
Risperidone-induced neuroleptic malignant syndrome: a case report.Ther Adv Psychopharmacol. 2022 May 14;12:20451253221094960. doi: 10.1177/20451253221094960. eCollection 2022. Ther Adv Psychopharmacol. 2022. PMID: 35586306 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
